Award
Definitive Contract #75A50123C00047
HHS Awards $81.77M for Pediatric Trauma Blood Resuscitation Study
Buyer
Office of Assistant Secretary for Preparedness and Response
Award Amount
$37,609,453.78
Ceiling
$99,317,105.78
Period of Performance
Sep 30, 2023 – May 31, 2030
Identifier
75A50123C00047
NAICS
541715
This definitive contract, awarded by the Department of Health and Human Services (HHS), involves the University of Pittsburgh - Of the Commonwealth System of Higher Education as the primary recipient. The contract aims to provide definitive evidence on the effectiveness, safety, and mechanisms of low titer group O whole blood (LTOWB) and tranexamic acid (TXA) as resuscitation strategies for life-threatening bleeding in children due to traumatic injuries. The contract has a potential total value of $81,775,886.00, with a performance period running from September 30, 2023, to September 29, 2033. There was no set-aside designation for this contract, which was awarded through full and open competition. Key subcontractors include Oregon Health & Science University, University of Texas Health Science Center at Houston, and University of Utah, all engaged in clinical and regulatory activities essential to the project's success. The significance of this contract lies in its potential to improve trauma care protocols and enhance survival rates among pediatric trauma patients.
Description
ADD ADDITIONAL FUNDING TO THE BASE PERIOD; UPDATE COA THRESHOLD TO $350,000; ADD BERYL VOIGT AS ALTERNATE COR; UPDATE FAR/HHSAR CLAUSES PER EXECUTIVE ORDERS AND REVOLUTIONARY FAR/HHSAR OVERHAUL (RFO); UPDATE SOW AND CONTRACT MILESTONES AND DELIVERABL